TransMedics Group, Inc. — Director's Dealing 2019

Aug 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2019-08-05

Reporting Person: DAMME LAURA (VP, Clinical Affairs)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-05	Stock Option (Right to Buy)	$21.89	A	18000	Acquired	2029-08-05	Common Stock (18000)	Direct

Footnotes

F1: The option vests as to 25% of the shares on the first anniversary of the vesting commencement date, August 1, 2019, and as to the remaining shares in equal monthly installments over three years thereafter.